top of page
Join the Early Adopters Advisory Group
Be among the first to transform cancer care with AI-driven proton therapy innovation.
AIDDA partners with selected clinics, hospitals, and research institutions in an Early Adopters program to support the development and validation of ProtonShot. Participants receive early access, dedicated support, and the opportunity to contribute to clinical and operational evidence generation.

bottom of page
